Maurey Christelle, Hislop Alison A, Advenier Charles, Vouhé Pascal R, Israël-Biet Dominique, Lévy Marilyne
UPRES EA220, Laboratoire d'Immuno-pathologie et de Pharmacologie Pulmonaires, Faculté de Médecine, Paris 5, UFR Biomedicale des Saints-Pères, 75006 Paris, France.
Pediatr Res. 2006 Sep;60(3):252-7. doi: 10.1203/01.pdr.0000233075.48306.57. Epub 2006 Jul 20.
Persistent pulmonary hypertension of the newborn is a life-threatening condition in which half of infants fail to respond to inhaled nitric oxide. Development of new therapeutic pathways is crucial. The adenosine triphosphate (ATP)-sensitive potassium channels (K(ATP)) may be important in this condition. Concentration-response curves to the K(ATP) channel opener (SR47063) were performed in isolated pulmonary arterial rings from normal newborn lambs (n = 8) and pulmonary hypertensive lambs (n = 7) induced by intrauterine ductus arteriosus ligation. The effect of endothelin (ET) receptor antagonists was analyzed. Expression in the lung of the subunit Kir 6.1 of the K(ATP) channel and of ET were analyzed using Western blot and immunohistochemistry. Relaxation to SR47063 was increased in ligated animals compared with the control group. Endothelium removal enhanced this response in ligated animals (p < 0.01). The inhibitory effect of the endothelium was reversed by the Endothelin-A receptor (ET-A) antagonist BQ 123 (p < 0.01). Kir 6.1 expression was not different between groups and that of endothelin-1 (ET-1) was increased threefold in ligated animals (p = 0.007). In pulmonary hypertensive lambs, vasodilation to K(ATP) channel openers was enhanced compared with controls and further potentiated by ET-A blockade. These data might lead to new therapeutic strategies in infants with pulmonary hypertension.
新生儿持续性肺动脉高压是一种危及生命的疾病,其中一半的婴儿对吸入一氧化氮无反应。开发新的治疗途径至关重要。三磷酸腺苷(ATP)敏感性钾通道(K(ATP))在这种疾病中可能很重要。在来自正常新生羔羊(n = 8)和通过子宫内动脉导管结扎诱导的肺动脉高压羔羊(n = 7)的离体肺动脉环中,进行了对K(ATP)通道开放剂(SR47063)的浓度-反应曲线实验。分析了内皮素(ET)受体拮抗剂的作用。使用蛋白质印迹法和免疫组织化学法分析了K(ATP)通道亚基Kir 6.1和ET在肺中的表达。与对照组相比,结扎动物对SR47063的舒张反应增强。去除内皮可增强结扎动物的这种反应(p < 0.01)。内皮素-A受体(ET-A)拮抗剂BQ 123可逆转内皮的抑制作用(p < 0.01)。各组之间Kir 6.1的表达无差异,结扎动物中内皮素-1(ET-1)的表达增加了三倍(p = 0.007)。在肺动脉高压羔羊中,与对照组相比,对K(ATP)通道开放剂的血管舒张作用增强,并且通过ET-A阻断进一步增强。这些数据可能会为肺动脉高压婴儿带来新的治疗策略。